PRMT5 and breast cancer: For example, protein arginine methyltransferase 5 (PRMT5) inhibits m6A methylation by enhancing the nuclear translocation of ALKBH5, further enhancing DNA repair capacity and thereby reducing the efficacy of doxorubicin in BC cells [152].